FCGR3A and hepatocellular carcinoma: This effect, as shown in our studies, is significantly more potent than ADCC mediated by the single anti-GPC3 antibody via Fc binding to CD16 on NK cells against HCC tumors and is an effective way of targeting NK cells against tumors.